SLC4A7 and cancer: Third, we demonstrate that pharmacological targeting of NBCn1 can decelerate tumor growth (Fig. 5d) and cancer cell expansion (Fig. 6c, d) and cause pH-dependent G2/M-phase cell cycle accumulation (Fig. 6f) and increased apoptosis (Fig. 6h).